Literature DB >> 7675967

Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man.

E Palazidou1, J Stephenson, J Butler, P Coskeran, S Chambers, A M McGregor.   

Abstract

The effects of pindolol pretreatment (2 days) on prolactin and cortisol responses to a single dose of (+)-fenfluramine (30 mg po) were examined in nine healthy male volunteers. Pindolol pretreatment attenuated the (+)-fenfluramine-induced increase in prolactin concentrations but failed to affect the (+)-fenfluramine-induced cortisol increase. These data provide evidence in support of 5-HT1A receptor involvement in the regulation of prolactin secretion but question its importance in the regulation of cortisol secretion in man.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675967     DOI: 10.1007/bf02246297

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans.

Authors:  K P Lesch; R Rupprecht; B Poten; U Müller; K Söhnle; J Fritze; H M Schulte
Journal:  Biol Psychiatry       Date:  1989-06       Impact factor: 13.382

2.  Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects.

Authors:  R S Kahn; O Kalus; S Wetzler; W Cahn; G M Asnis; H M van Praag
Journal:  Psychiatry Res       Date:  1990-08       Impact factor: 3.222

3.  Effect of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans--I. Growth hormone.

Authors:  G Laakmann; K Zygan; H W Schoen; A Weiss; M Wittmann; R Meissner; D Blaschke
Journal:  Psychoneuroendocrinology       Date:  1986       Impact factor: 4.905

4.  Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.

Authors:  E A Mueller; D L Murphy; T Sunderland
Journal:  J Clin Endocrinol Metab       Date:  1985-12       Impact factor: 5.958

5.  Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine.

Authors:  A Quattrone; G Tedeschi; U Aguglia; F Scopacasa; G F Direnzo; L Annunziato
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

Review 6.  Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness.

Authors:  S A Checkley
Journal:  Psychol Med       Date:  1980-02       Impact factor: 7.723

Review 7.  Is the ISA of pindolol beta 2-adrenoceptor selective?

Authors:  W H Aellig; B J Clark
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

8.  Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion.

Authors:  L D Van de Kar; S A Lorens; J H Urban; C L Bethea
Journal:  Neuropharmacology       Date:  1989-03       Impact factor: 5.250

9.  Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.

Authors:  D Oksenberg; S J Peroutka
Journal:  Biochem Pharmacol       Date:  1988-09-15       Impact factor: 5.858

10.  A central serotonin receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, has different effects on prolactin secretion in male and female rats.

Authors:  M Carlsson; E Eriksson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986-04
View more
  4 in total

1.  5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.

Authors:  E F Coccaro; R J Kavoussi; T B Cooper; R Hauger
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

2.  Analysis of T102C 5HT2A polymorphism in Brazilian psychiatric inpatients: relationship with suicidal behavior.

Authors:  H Correa; L De Marco; W Boson; M M Viana; V F S Lima; A C Campi-Azevedo; J C M Noronha; C Guatimosim; Marco A Romano-Silva
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

3.  Research on serotonin and suicidal behavior: neuroendocrine and molecular approaches.

Authors:  Humberto Corrêa; Marco Aurélio Romano-Silva; Fabrice Duval; Ana Carolina Campi-Azevedo; Vivtor Lima; Jean-Paul Macher
Journal:  Dialogues Clin Neurosci       Date:  2002-12       Impact factor: 5.986

4.  Serotonergic and noradrenergic function in depression: clinical correlates.

Authors:  F Duval; M C Mokrani; P Bailey; H Corrêa; M A Crocq; T Son Diep; J P Macher
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.